Immune Therapeutics Inc (OTCQB:IMUN)

0.075
Delayed Data
As of Apr 17
 +0.0084 / +12.61%
Today’s Change
0.05
Today|||52-Week Range
0.95
-55.88%
Year-to-Date
No recent news for Immune Therapeutics Inc.

Today’s Trading

Previous close0.07
Today’s open0.06
Day’s range0.06 - 0.08
Volume83,391
Average volume (3 months)363,160
Market cap$10.8M
Dividend yield--
Data as of 3:34pm ET, 04/17/2015

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book--

Competitors

No competitors data available.

Financials

Last reporting dateMay 29, 2013
EPS forecast (this quarter)-$0.29
Annual revenue (last year)--
Annual profit (last year)--
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Noreen Griffin
President &
Chief Operating Officer
Seth A. Elliott
Corporate headquarters
Orlando, Florida

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers